U.S. Water Utilities Stock News

NYSE:VLO
NYSE:VLOOil and Gas

Assessing Valero Energy’s Valuation After Profit Turnaround Dividend Affirmation And Improved Guidance

Valero Energy (VLO) has just paired a regular quarterly dividend of $1.20 per share with a sharp swing back to profitability in the first quarter, giving investors fresh numbers to reassess the stock. See our latest analysis for Valero Energy. The recent quarterly profit and steady dividend come against a share price of $236.35, with a 90 day share price return of 16.61% and a year to date share price return of 42.97%. The 1 year total shareholder return of 99.87% suggests strong momentum has...
NYSE:W
NYSE:WSpecialty Retail

Is Wayfair’s Q1 2026 Sales Growth And Narrower Loss Altering The Investment Case For Wayfair (W)?

Wayfair Inc. has reported past first-quarter 2026 results, with sales rising to US$2,931 million from US$2,730 million and its net loss narrowing to US$105 million from US$113 million a year earlier. The smaller basic and diluted loss per share, improving from US$0.89 to US$0.80, points to gradual operating progress even as the company remains unprofitable. With Wayfair showing higher quarterly sales and a reduced net loss, we’ll now assess how this shapes the company’s broader investment...
NasdaqGS:MDLZ
NasdaqGS:MDLZFood

How Investors May Respond To Mondelez International (MDLZ) Stronger Q1 Earnings And Inclusion-Focused Workforce Strategy

Mondelez International recently reported first-quarter 2026 results, with sales rising to US$10.08 billion and net income increasing to US$560 million, alongside higher basic and diluted earnings per share of US$0.44 from continuing operations. In addition, the company’s chief global inclusion and learning officer is scheduled to speak at the ISG Future Workplace Summit in New York, highlighting how its focus on workforce development and inclusion sits alongside its improving financial...
NasdaqGS:PCAR
NasdaqGS:PCARMachinery

Resilient Earnings And Higher Dividend Might Change The Case For Investing In PACCAR (PCAR)

PACCAR Inc’s board previously approved an increase in its regular quarterly cash dividend from US$0.33 to US$0.35 per share, payable on June 3, 2026, to shareholders of record as of May 13, 2026, while reporting first-quarter 2026 sales of US$6,234.3 million and net income of US$605.3 million. Although revenue declined compared with a year earlier, higher net income, earnings per share growth, and a higher dividend suggest management confidence in the company’s underlying profitability and...
NYSE:BKH
NYSE:BKHIntegrated Utilities

Assessing Whether Black Hills (BKH) Looks Undervalued After Recent Share Price Momentum

Why Black Hills Stock Is On Investors’ Radar Today Black Hills (BKH) is back in focus after recent trading, with the stock last closing at $75.22. For investors watching utilities, the company’s recent returns and scale offer fresh context for portfolio reviews. See our latest analysis for Black Hills. The recent 1 day share price return of 1.76% comes after a period of steadier gains, with a 30 day share price return of 3.06% and a year to date share price return of 8.00%. The 1 year total...
NasdaqGS:ONC
NasdaqGS:ONCBiotechs

BeOne Medicines (ONC) Is Up 7.4% After Guidance Hike And Priority Review Win In HER2 Cancer

In the past week, BeOne Medicines AG reported first-quarter 2026 results with revenue of US$1,513.44 million and net income of US$227.36 million, raised its full-year 2026 revenue and GAAP operating income guidance, and filed an omnibus shelf registration of up to about US$9.12 billion in various securities. The company also received FDA Priority Review and Breakthrough Therapy Designation for its TEVIMBRA and ZIIHERA combination in HER2-positive gastroesophageal adenocarcinoma, supported by...
NasdaqCM:PLSE
NasdaqCM:PLSEMedical Equipment

Taking A Fresh Look At Pulse Biosciences (PLSE) Valuation After New Atrial Fibrillation Trial Progress

Pulse Biosciences (PLSE) is drawing fresh attention after reporting favorable safety and efficacy data from a European feasibility study of its nPulse Cardiac Catheter System and beginning enrollment in a U.S. pivotal atrial fibrillation trial. See our latest analysis for Pulse Biosciences. At the latest share price of $19.61, Pulse Biosciences shows a 46.45% year to date share price return and a 157.69% three year total shareholder return, which indicates long term momentum despite recent...
NYSE:PSX
NYSE:PSXOil and Gas

Phillips 66 (PSX) Is Down 6.1% After Refining-Led Q1 Earnings Beat - Has The Bull Case Changed?

In the first quarter of 2026, Phillips 66 reported revenue of US$33.00 billion and net income of US$207 million, with earnings per share from continuing operations of US$0.51, reflecting solid refining margins and improved performance in chemicals and renewable fuels. Analysts highlighted that stronger refining margins and better results in chemicals and renewable fuels underpinned the earnings beat, reinforcing management’s emphasis on an integrated business model, capital discipline, and...
NYSE:DOCN
NYSE:DOCNIT

A Look At DigitalOcean Holdings (DOCN) Valuation After Q1 Results Guidance Upgrades And New AI Infrastructure Launches

DigitalOcean Holdings (DOCN) has quickly moved back onto investor radar following first quarter 2026 results, higher revenue guidance for 2026 and 2027, and new AI infrastructure launches that have reset expectations for the stock. See our latest analysis for DigitalOcean Holdings. The share price has been on a sharp upswing, with a 30-day share price return of 73.73% and a 90-day share price return of 139.08%. The 1-year total shareholder return of 403.28% highlights how strongly recent...
NasdaqGS:SATS
NasdaqGS:SATSMedia

Will EchoStar's (SATS) Growing Role as a SpaceX Proxy Reshape Its Core Investment Narrative

In early May 2026, EchoStar drew attention as investors increasingly framed the company as an indirect way to access SpaceX, while operational segments, regulatory issues, and recent insider share sales added complexity to its story. A key development was FMR LLC disclosing a 10.1% stake in EchoStar, highlighting growing institutional interest even as analysts debate whether the shares look overvalued. Next, we’ll examine how EchoStar’s emerging role as a proxy for SpaceX exposure interacts...
NYSE:NUVB
NYSE:NUVBPharmaceuticals

A Look At Nuvation Bio (NUVB) Valuation After Profit Shift And Taletrectinib FDA And Guideline Milestones

Nuvation Bio (NUVB) has drawn fresh attention after reporting first quarter revenue of US$83.23 million and a profit of US$5.4 million, alongside new FDA and guideline milestones for its oncology drug IBTROZI. See our latest analysis for Nuvation Bio. The stock has been volatile, with a 1-day share price return of a 4.56% decline following a strong 7-day share price return of 8.09%. The year-to-date share price return of a 43.94% decline contrasts with a very large 1-year total shareholder...
NYSE:FTV
NYSE:FTVMachinery

Reaffirmed EPS Guidance and AI Momentum Could Be A Game Changer For Fortive (FTV)

Fortive recently reported first-quarter 2026 results showing revenue of US$1,069.4 million and net income of US$136.4 million, while also boosting its share repurchase authorization to 72,378,691 shares with 20,000,000 shares remaining available. Behind the headlines, management highlighted strong demand in Intelligent Operating Solutions and Advanced Healthcare Solutions, with AI-enhanced and recurring-revenue offerings growing faster than overall sales and supporting the reaffirmed...
NYSE:CWK
NYSE:CWKReal Estate

How Record AI Leasing and One-Off Pension Loss Will Impact Cushman & Wakefield (CWK) Investors

Cushman & Wakefield recently reported past first-quarter 2026 results with revenue rising to US$2,535.8 million from US$2,284.6 million a year earlier, while shifting from net income of US$1.9 million to a net loss of US$12.6 million largely tied to one-off pension-related items. Alongside record leasing activity driven by data centers and other AI-related demand, the firm reaffirmed its full-year outlook and continued reducing leverage, indicating operational momentum despite the quarterly...
NYSE:KEYS
NYSE:KEYSElectronic

Is Earnings Beat And EV Push Altering The Investment Case For Keysight Technologies (KEYS)?

Recently, Keysight Technologies reported earnings and guidance that exceeded expectations, supported by broad-based demand in AI infrastructure, aerospace and defense, and semiconductors, while also launching a PCIe 7.0 receiver test solution and deepening its collaboration on electric-vehicle charging standards in China. Together, these developments highlight how Keysight is pairing strong current execution with product and partnership innovation in emerging areas like high-speed computing...
NasdaqGS:ALKT
NasdaqGS:ALKTSoftware

Alkami Technology (ALKT) Is Up 10.5% After New Buyback And GAAP Guidance Update - Has The Bull Case Changed?

In late April 2026, Alkami Technology, Inc. reported first-quarter 2026 results showing US$126.14 million in sales and a net loss of US$9.96 million, issued GAAP revenue guidance of US$128.0–129.0 million for the second quarter and US$527.1–530.9 million for 2026, and authorized a US$100 million share repurchase program supported by a credit agreement amendment. At the same time, General Atlantic–affiliated funds increased their ownership to 16.3% of Alkami’s shares, obtained board approval...
NasdaqGS:FORM
NasdaqGS:FORMSemiconductor

Assessing FormFactor (FORM) Valuation After Strong Q1 Results And Record Q2 Guidance

FormFactor (FORM) is back on investors’ radar after first quarter 2026 earnings, with sales of US$226.14 million and net income of US$20.38 million, along with Q2 guidance pointing to record quarterly revenue. See our latest analysis for FormFactor. The strong first quarter and guidance have come alongside sharp share price momentum, with a 30 day share price return of 37.63% and a year to date share price return of 144.43%, while the 1 year total shareholder return is very large. If...
NYSE:SLG
NYSE:SLGOffice REITs

A Look At SL Green Realty (SLG) Valuation As One Madison Avenue Wins Award And Reaches Full Leasing

SL Green Realty (SLG) is back in focus after its One Madison Avenue project received the 2026 Urban Land Institute Award for Excellence in Development and reached 100% leasing, alongside flagship peer asset One Vanderbilt. See our latest analysis for SL Green Realty. The award recognition comes as momentum in SL Green Realty’s stock has picked up, with a 6.77% 7 day share price return and a 20.55% 30 day share price return. The 1 year total shareholder return is a 14.13% loss, while the 3...
NYSE:SPXC
NYSE:SPXCMachinery

A Look At SPX Technologies (SPXC) Valuation After Raised 2026 Revenue Guidance And Strong Q1 Results

SPX Technologies (SPXC) drew investor attention after first quarter sales reached US$566.8 million with net income of US$59.9 million, alongside higher full year 2026 revenue guidance in the range of US$2.575 billion to US$2.645 billion. See our latest analysis for SPX Technologies. The latest earnings update and raised 2026 revenue guidance came as the share price has been relatively flat year to date, with a 0.99% share price return. Total shareholder return over the past year is 37.43%,...
NasdaqGS:GPRE
NasdaqGS:GPREOil and Gas

Green Plains (GPRE) Is Down 5.3% After Profitable Quarter On Lower Production And Revenue - Has The Bull Case Changed?

In the first quarter ended March 31, 2026, Green Plains Inc. reported US$445.8 million in sales, US$32.94 million in net income and lower year-on-year production across ethanol, distillers grains, ultra-high protein and renewable corn oil. The return to profitability despite reduced volumes and revenue highlights how cost control and mix improvements can influence Green Plains’ earnings profile. Next, we’ll examine how Green Plains’ return to profitability on reduced production and revenue...
NYSE:BWA
NYSE:BWAAuto Components

BorgWarner’s Reaffirmed 2026 Outlook and EV Wins Might Change The Case For Investing In BWA

In early May 2026, BorgWarner reported first‑quarter 2026 sales of US$3,533 million and net income of US$242 million, while maintaining full‑year guidance that targets net sales of US$14.00–US$14.30 billion and a U.S. GAAP operating margin of 9.7%–9.9%. A wave of recent program wins in electrified and emissions-focused technologies, spanning Asian eMotor awards and a Euro 7 commercial vehicle platform, suggests BorgWarner is deepening its role in next‑generation propulsion across both...
NasdaqGM:LNTH
NasdaqGM:LNTHMedical Equipment

Assessing Lantheus Holdings (LNTH) Valuation After Recent Share Price Momentum

Recent performance and business snapshot Lantheus Holdings (LNTH) has drawn attention after a stretch of strong share price performance, with the stock up over the past week, month and past 3 months, while also showing a double digit 1 year total return. The company develops diagnostic and therapeutic products used in the detection and treatment of heart disease, cancer and other conditions, reporting revenue of US$1,546.178 million and net income of US$279.031 million from its portfolio of...
NYSE:VAC
NYSE:VACHospitality

A Look At Marriott Vacations Worldwide (VAC) Valuation After Raised 2026 Contract Sales Guidance

Why Marriott Vacations Worldwide (VAC) Is Back in Focus Marriott Vacations Worldwide (VAC) is back on investors’ radar after reporting first quarter 2026 results alongside higher full year contract sales guidance, reflecting a combination of mixed profitability and a more confident outlook for the rest of the year. See our latest analysis for Marriott Vacations Worldwide. VAC’s share price has climbed in recent months, with a 30 day share price return of 18.77% and a 90 day gain of 38.81%...
NasdaqGS:ARQT
NasdaqGS:ARQTBiotechs

A Look At Arcutis Biotherapeutics (ARQT) Valuation After Q1 2026 Results And ZORYVE Label Expansion Efforts

Arcutis Biotherapeutics (ARQT) is in focus after reporting Q1 2026 revenue of US$105.4 million, a narrowed net loss of US$11.3 million, positive operating cash flow, and reaffirmed full year revenue guidance. See our latest analysis for Arcutis Biotherapeutics. The stock closed at US$20.66 after the results, with a 1-day share price return of -14.52% and a year to date share price return of -28.76%. However, the 1-year total shareholder return is 52.87%, which suggests recent momentum has...
NasdaqGS:MKTX
NasdaqGS:MKTXCapital Markets

Assessing MarketAxess (MKTX) Valuation After Q1 2026 Earnings Beat And Share Buyback Completion

MarketAxess Holdings (MKTX) is back in focus after first quarter 2026 earnings, reporting revenue of US$233.38 million and net income of US$77.88 million, alongside the completion of a US$300 million share repurchase program. See our latest analysis for MarketAxess Holdings. The earnings beat and new partnership with Moment come after a tougher stretch for holders, with the share price down 14.5% year to date and a 1 year total shareholder return of 31.41% in decline. This suggests sentiment...